B L Neubauer - JoVE Visualize

Showing results (21-30 of 38) with videos related to

Pageof 4

Sort By:

The Journal of Urology|February 1, 1992

Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984B L Neubauer, R L Merriman, K L Best, et al.

The Prostate. Supplement|January 1, 1996

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5alpha-reductase inhibitorD M Sutkowski, J E Audia, R L Goode, et al.

Journal of the National Cancer Institute|October 8, 1999

Growth regulation of prostatic stromal cells by prostate-specific antigenD M Sutkowski, R L Goode, J Baniel, et al.

The Journal of Urology|January 1, 1986

Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the ratB L Neubauer, K G Bemis, K L Best, et al.

The Prostate|January 1, 1986

Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the ratB L Neubauer, K G Bemis, K L Best, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001

Expression of group IIa secretory phospholipase A2 increases with prostate tumor gradeJ R Graff, B W Konicek, J A Deddens, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993

LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1K S Hirsch, C D Jones, J E Audia, et al.

Thrombosis Research|April 1, 1988

Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the ratG F Smith, B L Neubauer, J L Sundboom, et al.

Toxicology and Applied Pharmacology|February 1, 1990

Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male ratB L Neubauer, R L Goode, K L Best, et al.

The Prostate|January 1, 1993

LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male ratsB L Neubauer, K L Best, T R Blohm, et al.

Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:

Pageof 4

The Journal of Urology|February 1, 1992

Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984B L Neubauer, R L Merriman, K L Best, et al.

The Prostate. Supplement|January 1, 1996

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5alpha-reductase inhibitorD M Sutkowski, J E Audia, R L Goode, et al.

Journal of the National Cancer Institute|October 8, 1999

Growth regulation of prostatic stromal cells by prostate-specific antigenD M Sutkowski, R L Goode, J Baniel, et al.

The Journal of Urology|January 1, 1986

Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the ratB L Neubauer, K G Bemis, K L Best, et al.

The Prostate|January 1, 1986

Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the ratB L Neubauer, K G Bemis, K L Best, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001

Expression of group IIa secretory phospholipase A2 increases with prostate tumor gradeJ R Graff, B W Konicek, J A Deddens, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993

LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1K S Hirsch, C D Jones, J E Audia, et al.

Thrombosis Research|April 1, 1988

Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the ratG F Smith, B L Neubauer, J L Sundboom, et al.

Toxicology and Applied Pharmacology|February 1, 1990

Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male ratB L Neubauer, R L Goode, K L Best, et al.

The Prostate|January 1, 1993

LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male ratsB L Neubauer, K L Best, T R Blohm, et al.

Pageof 4